Human T-cell leukemia virus type I (HTLV-I) is a causative agent of neoplastic disease, adult T-cell leukemia (ATL). Although the encoding viral proteins play an important role in oncogenesis, the role of the HTLV-I proviral integration site remains unsolved.
Introduction
After infection with retrovirus, reverse transcriptase synthesizes proviral DNA and then integrates the provirus into the host genome by the action of an integrase. In some retrovirus-associated neoplasms, provirus insertion enhances the transcription of oncogenes, such as the myc gene, resulting in transformation of infected cells. 1, 2 Although the integration sites of proviruses in the host genome have been considered random, recent studies regarding various retroviruses revealed that human immunodeficiency virus type 1 (HIV-1) prefer transcriptional units 3 whereas murine leukemia virus (MLV) tend to integrate near the transcriptional start sites. 4 These findings suggest that the integration of proviruses depends on mechanisms unique to each retrovirus, which interact with host factors associated with nuclear transport, DNA repair and chromatin structure. Although it has been reported that the integration sites of HTLV-I provirus are random, preferential integration into the transcriptional units has been reported in ATL cells. 12, 13 In this study, we compared HTLV-I integration sites between carriers and leukemic cells, and found that the provirus was frequently integrated into alphoid repetitive sequences in the carrier state, but not the leukemic state.
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Materials and methods

Patients
Peripheral blood mononuclear cells (PBMCs) were separated from heparinized peripheral blood by Ficoll-Hypaque density gradient centrifugation. They were then digested with proteinase K and treated with RNase A to eliminate RNA. Genomic DNAs were extracted from the PBMCs of 16 HTLV-I carriers and 59 patients with ATL.
Approval for this study was obtained from the institutional review board of the Kyoto University. The informed consent was obtained from blood donors and patients according to the Declaration of Helsinki.
Inverse long PCR (IL PCR)
IL PCR was used to amplify the genomic DNA adjacent to the integration sites of the HTLV-I provirus. First, genomic DNA (1.5 µg) was digested with a restriction enzyme (HindIII, PstI or EcoRI), then ligated by T4 DNA ligase. When DNA was digested with EcoRI, it was digested with MluI after ligation so as not to amplify the HTLV-I provirus itself. The resulting DNA was used as a substrate for IL PCR, which was performed using TaKaRa LA PCR TM (Takara, Shiga. Japan). Briefly, primers (final concentration, 0.2 µM), MgCl 2 (2.5 mM) and dNTPs (0.4 mM) were mixed (total 20 µl) then AmpliWax (Applied Biosystems, Norwalk, CT) was added to each tube. After wax layer formation by incubation at 80°C for 10 min and cooling at room temperature for 15 min, substrate DNA (0.5 µg), 10 × LA buffer (5 µl), and LA Taq (0.4 µl) were added (total 30 µl). Cycles for long PCR were as follows: one cycle of 98°C for 2 min, 5 cycles of 98°C 6   for 30 s and 64°C for 10 min, and 35 cycles of 94°C for 30 s, 64°C for 10 min and 72°C for 15 min. The primers used in this experiment were as follows: primers 1 and 2 were used for PstI-digested samples, primer 1:
5'-TGGAATGTTGGGGGTTGTATGAGTGATTGG-3'. Primers 1 and 3 were used for
HindIII-digested samples, primer 3: 5'-TGGGCAGGATTGCAGGGTTTAGAGTGG-3'.
Primers 4 and 5 were used for EcoRI-digested samples, primer 4:
5'-AGTCT-GGGCCCTGACCTTTTCAGACTTCTGTTTC-3'.
Cloning and sequencing
IL PCR products from ATL samples were used as a template for direct sequencing to determine the integration site. The primer used for sequencing was as follows:
5'-TCATTCACGACTGACTGCCGG-3'. To determine integration sites from carrier samples, IL PCR products were gel-isolated using a QIAquick Gel Extraction Kit 
Mapping integration sites
The BLAST-Like Alignment Tool program was used to map sequences to the human 14 Sequence matches were judged to be authentic only if they (1) contained the LTR sequence, (2) showed 95% or greater identity to the genomic sequence over the high quality sequence region, and (3) matched only one genomic locus with 95% or greater identity. Genomic features such as coding regions and repetitive sequences were investigated using the UCSC Genome Browser. Random integration sites (10,000×) in non-gap regions of the human genome (UCSC Human Genome Project Working Draft, July 2003 freeze) were generated with a computer program using a uniform distribution algorithm, and used for comparison with the observed HTLV-I integration sites. 
Statistical analyses
Results
HTLV-I provirus integration sites
We determined the genomic sequences adjacent to the HTLV-I provirus integration sites in ATL cells (59 cases) and HTLV-I-infected cells (56 sites) in the 16 carriers by inverse PCR, and then analyzed 1) chromosomal locations, 2) the genes containing integration sites or neighboring genes, 3) the relation of transcriptional direction between provirus and cellular genes when the HTLV-I provirus was integrated within the gene, 4) distance from the transcriptional start site, and 5) repetitive sequences. These results are summarized in Table 1 .
As reported previously, 15, 16 the integration sites of HTLV-I provirus were random in both leukemic cells and carriers ( (Table 2) . As a control, we simulated random HTLV-1 integration by placing 10,000 integration sites randomly into the same human genome, of which 33.2 % were found within the transcription units (Table 2) , a percentage identical to the estimated transcribed human genome. 17, 18 Although the frequency of integration into transcriptional units was low in carriers, the difference between the carriers and ATL cells was not statistically significant.
Since annotation for the human genome has been changing rapidly in the last few years, the previous reports on HTLV-I integration sites should be re-examined. 12, 13 The frequency of integration into the transcriptional units has reduced to 46.6 from 56.4%. Therefore, we investigated the relationship of transcriptional direction between cellular genes and type 2 defective provirus. In two of four cases with type 2 defective provirus, the provirus was integrated into transcriptional units, which were mutated in colorectal cancers (MCC) and protocadherin 9 genes (Table 1) . HTLV-I provirus was inserted in both genes in a sense direction, suggesting that the promoter of cellular genes might transcribe the viral genes in such cases.
HTLV-I provirus tends to be integrated near the transcriptional start sites in leukemic cells
In the MLV, the provirus tended to be integrated near the transcriptional start sites 4 . On the other hand, HIV-1 has no such tendency in spite of its preference for transcriptional units. Since HTLV-I is a human retrovirus, it is of interest to determine whether HTLV-I has a similar tendency to MLV or HIV-1. In HTLV-I, 9 of the 59 proviruses were integrated near the transcriptional start sites (± 5kb) in ATL cells (9/59: 15.3%) as shown in Table 3 and Figure 2 . In contrast, using the same genome assembly, only 5.6% of the random integration landed near transcriptional start sites. Hence, the frequency of integration near the transcriptional start sites was statistically significant (p=0.006), which is similar to MLV. Since the number of integration within ± 5kb from transcription start sites is only three, there is no preference of integration near the transcriptional start sites.
Integration sites in repetitive sequences
Next, we studied the relationship between repetitive sequences and integration sites.
Percentages of repetitive sequences in human genome were based on the previous report by Venter et al. 18 Among the carriers, 11 sites (11/56; 20%) resided in the alphoid repetitive sequences, which are a component of centromeric heterochromatin and has a monomeric repeating unit of 171 bp, 21 , whereas only two integration sites were identified within alphoid sequences in ATL (2/59; 3.4%). Since alphoid sequences were estimated to compose 3-5% of the human genome, we used 5% for the statistical analyses (Table 4) 
Discussion
Recent studies on the integration sites of proviruses have provided new insights into the mechanism of integration and pathogenesis of retroviral infections. 3, 4, 22 In MLV, indicating that HIV-1 integration targets transcriptional active regions more than expected from in vitro data. On the other hand, this report showed that integration of the HTLV-I provirus into transcriptional units was not frequent compared with random integration, which is not consistent to the previous studies. 12, 13 This is because of the changing database. We analyzed the integration sites and genes by the UCSC Genome Browser (July, 2003) . In HTLV-I carriers, integration into the transcriptional units was rather less frequent than random integration although the difference was not statistically significant. Combined with the finding that HTLV-I tends to be integrated near the transcriptional start sites, the pattern of HTLV-I integration is similar to that of MLV rather than that of another human retrovirus, HIV-1.
In the carrier state, HTLV-I provirus tends to be integrated into alphoid repetitive sequences, whereas the frequency of integration into alphoid sequences was significantly decreased in leukemic cells. When HIV-1 provirus is integrated into alphoid sequences, it establishes a latent infection by influencing the surrounding heterochromatin in vitro. Since transcriptional active sites are associated with nuclear transport machinery, 28 preintegration complexes that pass through the nuclear pore might be integrated into It is possible that this provirus traps the cellular promoter thus ensuring transcription. In this study, the provirus of two of the four cases with type 2 defective provirus was integrated in the transcriptional unit in a sense orientation, indicating that the cellular promoter might transcribe the viral gene. In addition, HTLV-I provirus contains an internal promoter sequence in the pol region, 29 which is considered to transcribe the viral gene. This is thought to have occurred especially in the remaining two cases, which showed integration of the provirus outside the transcriptional units.
In HTLV-1-induced oncogenesis, viral proteins such as Tax promote the proliferation of HTLV-I infected cells and induce ATL in about 2-6% of carriers after a long latent period. 7, 8 Since HTLV-I provirus integration is random, 15 integration itself does not directly influence leukemogenesis. Viral products such as Tax promote the proliferation of HTLV-I infected cells and induce transformation of infected T-lymphocytes. 30, 31 However, expression of Tax protein is impaired by several mechanisms in ATL cells,
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including deletion of 5'-LTR, 19 DNA methylation of 5'-LTR, 32 and genetic changes (deletion, insertion and non-sense mutations) of the tax gene itself. 33, 34 In the carrier state, presence of the Tax protein is advantageous for the proliferation and survival of infected cells, however, since Tax is the major target of CTL in vivo, NS and UN mean 'not significant' and 'unknown' respectively.
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